Research is an essential element of Pelican’s aim to improving cancer surgery.
The Pelican Research Centre develops and manages research that will help to influence the way we treat pelvic and liver cancers in the near future. Our focus is on clinical trials – those that involve people – as they bring the latest treatments and approaches to today’s cancer patients.
We sponsor research that is relevant to the staging and treatment of bowel, liver, prostate and bladder cancers and related diseases. We look for excellence, timeliness and originality of science, preferring research that includes the multi-disciplinary perspective and takes account of Department of Health and NHS priorities and needs.
Pelican has invested over £2 million in innovative research. Our grants range from £6,000-£100,000 and the research projects have lasted from 6 months to several years. Pelican is a member of the Association of Medical Research Charities (AMRC) and a partner organisation of the National Institute of Health Research.
Pelican is interested in hearing proposals covering our areas of interest
All of the grants that Pelican give supporting innovative research are funded through voluntary means. We rely entirely on generous donations from the public and grants from various funds or trusts to help carry out this important work. We are enormously grateful to all those who have supported us so far and, with your help, we hope to continue to contribute to beneficial research in the future. If you are interested in supporting the research that Pelican is involved in please visit our ‘can you help?' page for further information.
To find out more about the research Pelican is involved in please follow the links below:
How our research changes cancer care
Our Research Grants have initiated studies which have later gained multi-million pound grants from other organisations, including Cancer Research UK.
We are currently supporting 2 exciting studies in bowel cancer: Minstrel, which will help identify treatment pathways, and Flex, which could lead to patients with bowel polyps avoiding some of the risks of major surgery. We are also funding a Colorectal Peritoneal Malignancy Registry which will help specialists gain a better understanding of different treatments by comparing patient outcomes across the country.
We are currently reviewing new cutting-edge research proposals for our 2016 grants.
You can find out more about our research in this section of the website.